Search research articles
Contact Us
Filters
Showing results (151-160 of 361) with videos related to
Page
of 37
Sort By:
Clinical Science and Molecular Medicine
|
November 1, 1975
Urinary excretion of 17-oxosteroids in hereditary coproporphyria
J W Paxton, M R Moore, A D Beattie, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems
|
January 1, 1989
Action of lead on neurotransmission in rats
M J McIntosh, P A Meredith, M R Moore, et al.
Neuropharmacology
|
February 1, 1986
Effects of lead in the laboratory mouse--2. Development and social behaviour after lifelong administration of a small dose of lead acetate in drinking fluid
J M Donald, M G Cutler, M R Moore, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology
|
June 1, 2000
Chronic toxicity of di(2-ethylhexyl)phthalate in rats
R M David, M R Moore, D C Finney, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology
|
December 2, 2000
Chronic toxicity of di(2-ethylhexyl)phthalate in mice
R M David, M R Moore, D C Finney, et al.
Toxicologic Pathology
|
September 19, 2001
Reversibility of the chronic effects of di(2-ethylhexyl)phthalate
R M David, M R Moore, D C Finney, et al.
European Journal of Clinical Pharmacology
|
November 14, 1977
The effects of industrial lead poisoning on cytochrome P450 mediated phenazone (antipyrine) hydroxylation
P A Meredith, B C Campbell, M R Moore, et al.
Journal of Psychopharmacology (Oxford, England)
|
February 3, 2012
Lofepramine--a safe anti-depressant in acute hepatic porphyria?
S B Dover, A Graham, M R Moore, et al.
Gut
|
August 1, 1994
Safety of general anaesthesia and surgery in acute hepatic porphyria
S B Dover, L Plenderleith, M R Moore, et al.
Cancer Treatment Reports
|
July 1, 1976
Phase I trial of dianhydrogalactitol administered Iv in a weekly schedule
C L Vogel, E F Winton, M R Moore, et al.
Page
of 37
Search research articles
Search
Showing results (151-160 of 361) with videos related to
Sort By:
Page
of 37
Clinical Science and Molecular Medicine
|
November 1, 1975
Urinary excretion of 17-oxosteroids in hereditary coproporphyria
J W Paxton, M R Moore, A D Beattie, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems
|
January 1, 1989
Action of lead on neurotransmission in rats
M J McIntosh, P A Meredith, M R Moore, et al.
Neuropharmacology
|
February 1, 1986
Effects of lead in the laboratory mouse--2. Development and social behaviour after lifelong administration of a small dose of lead acetate in drinking fluid
J M Donald, M G Cutler, M R Moore, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology
|
June 1, 2000
Chronic toxicity of di(2-ethylhexyl)phthalate in rats
R M David, M R Moore, D C Finney, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology
|
December 2, 2000
Chronic toxicity of di(2-ethylhexyl)phthalate in mice
R M David, M R Moore, D C Finney, et al.
Toxicologic Pathology
|
September 19, 2001
Reversibility of the chronic effects of di(2-ethylhexyl)phthalate
R M David, M R Moore, D C Finney, et al.
European Journal of Clinical Pharmacology
|
November 14, 1977
The effects of industrial lead poisoning on cytochrome P450 mediated phenazone (antipyrine) hydroxylation
P A Meredith, B C Campbell, M R Moore, et al.
Journal of Psychopharmacology (Oxford, England)
|
February 3, 2012
Lofepramine--a safe anti-depressant in acute hepatic porphyria?
S B Dover, A Graham, M R Moore, et al.
Gut
|
August 1, 1994
Safety of general anaesthesia and surgery in acute hepatic porphyria
S B Dover, L Plenderleith, M R Moore, et al.
Cancer Treatment Reports
|
July 1, 1976
Phase I trial of dianhydrogalactitol administered Iv in a weekly schedule
C L Vogel, E F Winton, M R Moore, et al.
Page
of 37